Are regimens containing rituximab effective in the initial treatment of Epstein-Barr virus-positive natural killer cell lymphoproliferative disease-associated hemophagocytic lymphohistiocytosis?
about
Are regimens containing rituximab effective in the initial treatment of Epstein-Barr virus-positive natural killer cell lymphoproliferative disease-associated hemophagocytic lymphohistiocytosis?
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Are regimens containing rituxi ...... hagocytic lymphohistiocytosis?
@en
Are regimens containing rituxi ...... hagocytic lymphohistiocytosis?
@nl
type
label
Are regimens containing rituxi ...... hagocytic lymphohistiocytosis?
@en
Are regimens containing rituxi ...... hagocytic lymphohistiocytosis?
@nl
prefLabel
Are regimens containing rituxi ...... hagocytic lymphohistiocytosis?
@en
Are regimens containing rituxi ...... hagocytic lymphohistiocytosis?
@nl
P2093
P2860
P1476
Are regimens containing rituxi ...... hagocytic lymphohistiocytosis?
@en
P2093
Akihiro Yachie
Kagekatsu Kubo
Naoko Kudo
Shinsaku Imashuku
P2860
P2888
P304
P356
10.1007/S12185-013-1419-4
P577
2013-08-22T00:00:00Z